Were not in the business of selling "supplements"
It holds promise in various disease conditions, particularly in inflammatory bowel disease (IBD) treatment, where it has shown substantial

Areas Without Adequate Human Evidence Cardiovascular safety Neurological and psychiatric effects Liver and kidney safety Effects on blood glucose in humans Effects on methylation pathways Genotoxicity Carcinogenicity Reproductive and developmental toxicity Use during pregnancy or breastfeeding Interactions with prescription medicines Interactions with supplements or research compounds Long-term exposure Product-Quality Risks Incorrect quinolinium compound Wrong substitution position Incorrect counterion Incorrect active-content calculation Residual starting materials Residual solvents Degradation products Heavy-metal or inorganic contamination Mismatched certificate of analysis Uncontrolled storage and transport Absence of published harm is not proof of safety A compound without routine regulated human exposure may generate very few formal safety reports simply because there is no organised pharmacovigilance system

Individuals with Gastrointestinal Conditions: Certain gastrointestinal conditions, such as celiac disease, Crohns disease, or gastrointestinal surgery, can impair nutrient absorption
Other Modifiers: Depending on the situation, additional modifiers may be required: XE Separate encounter XP Separate practitioner 76 / 77 Repeat procedure (same or different provider) LT / RT Side of the body JW / JZ Drug wastage reporting The correct use of modifiers ensures that claims are processed accurately and reduces the risk of denials
Heres everything you need to know about Vitamin B-12 injections